• OTS
  • September 30, 2018
SHARE
Post Views: 782

Ruiz Ciancio D, Vargas MR, Thiel WH, Bruno MA, Giangrande PH, Mestre MB.
Pharmaceuticals (Basel). 2018 Sep 11;11(3).

PubMed

Related articles

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

April 23rd, 2021
Recent progress in non-native nucleic acid modifications

Recent progress in non-native nucleic acid modifications

April 23rd, 2021
Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement through post-transcriptional regulation

April 23rd, 2021
Hovlinc is a recently evolved class of ribozyme found in human lncRNA

Hovlinc is a recently evolved class of ribozyme found in human lncRNA

April 23rd, 2021
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown

Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown

April 23rd, 2021
Antisense Technology: A Review.

Antisense Technology: A Review.

March 15th, 2021